E. Carballo

发表

Tolerance and efficacy of subcutaneous interferon-beta administered for treatment of chronic hepatitis C.

M. Diago, V. Carreño, J. Quiroga, 1997, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Interferon alpha for the treatment of chronic hepatitis C in patients infected with human immunodeficiency virus. Hepatitis-HIV Spanish Study Group.

J. Castilla, J. del Romero, J. González-lahoz, 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

brasiliensis Mycelial Polysaccharide of a Sulfated Derivative of Agaricus Anti-Herpes Simplex Virus Activity In Vivo

M. Rossi, C. Brandt, C. M. Camelini, 2014 .

Interferon α for the Treatment of Chronic Hepatitis C in Patients Infected with Human Immunodeficiency Virus

J. Castilla, V. Soriano, J. González-lahoz, 1996 .

In Vivo Anti-Herpes Simplex Virus Activity of a Sulfated Derivative of Agaricus brasiliensis Mycelial Polysaccharide

M. Rossi, C. M. Simões, C. Brandt, 2013, Antimicrobial Agents and Chemotherapy.

A cationic peptide, TAT-Cd°, inhibits herpes simplex virus type 1 ocular infection in vivo.

C. Brandt, I. Larsen, E. Carballo, 2013, Investigative ophthalmology & visual science.

Efficacy and safety of alpha-interferon treatment for chronic hepatitis C in HIV-infected patients. HIV-Hepatitis Spanish Study Group.

J. Llibre, J. García-Samaniego, V. Soriano, 1995, The Journal of infection.

Multicenter randomized, controlled study of intramuscular administration of interferon-beta for the treatment of chronic hepatitis C.

M. Diago, V. Carreño, J. Such, 1997, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

CD4+ T-lymphocytopenia in HIV-infected patients receiving interferon therapy for chronic hepatitis C. HIV-Hepatitis Spanish Study Group.

J. Vicario, V. Soriano, Á. Castro, 1994, AIDS.

[The treatment of chronic hepatitis C with interferon in patients infected with the human immunodeficiency virus. The Spanish Group for the Study of Viral Hepatitis in HIV+ Patients].

J. Castilla, J. del Romero, J. González-lahoz, 1996, Medicina clinica.

Association of HCV and HBV markers in Spanish HIV-seropositive patients in relation to risk practices.

M. L. Rodriguez-Mendez, A. González-Quintela, A. Aguilera, 2003, Hepato-gastroenterology.

Circulating Hepatitis C Virus Genotypes in Spain

J. García-Samaniego, Á. Castro, P. Martínez-Odriozola, 1996 .

Epidemiology of HIV-2 infection in Spain

A. Heredia, V. Soriano, I. Hewlett, 1996, European Journal of Clinical Microbiology and Infectious Diseases.

Epidemiology of HIV-2 infection in Spain. The HIV-2 Spanish Study Group.

V. Soriano, A. Aguilera, J. González-lahoz, 1996, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology.

[Prevalence of the genotypes of the hepatitis C virus in Spanish drug addicts with chronic hepatitis C. Spanish Group for the Study of Viral Hepatitis in HIV Positive Patients].

J. González-lahoz, J. García-Samaniego, V. Soriano, 1996, Revista clinica espanola.